from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2323c/-

LFCtreatmentdescriptionclass of inhibitor

0.018

Amikacinug/mL Amikacintranslation

-0.277

Cap5-10ug/mL Capreomycintranslation

0.397

Rox10-50 ug/mL Roxithromycintranslation

0.246

SM2-5 ug/mL Streptomycintranslation

-0.950

Tet5-10 ug/mL Tetracyclinetranslation

0.077

Rif0.2-5ug/mL Rifampicintranscription

-0.158

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.294

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.251

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.580

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.321

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.656

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.897

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.566

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.623

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.816

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.052

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.137

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.229

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.214

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.173

Nigericin50 uM Nigericinrespiration

1.309

TRC10-150 ug/mL Triclosanrespiration

1.596

TRZ10-25 ug/mL Thioridazinerespiration

1.797

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.214

menadione6-10 ug/mL Menadionerespiration

-0.247

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.296

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.308

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.393

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.864

NRP_1Non-replicating persistence stage 1dosRassociated

-0.141

Amp0.2mg/mL AmpicillincellWall

-0.215

Cephalexin20-100 ug/mL CephalexincellWall

0.358

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.156

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.094

EMB10-20 ug/mL EthambutolcellWall

-0.371

Eta12-40 ug/mL EthionamidecellWall

-0.443

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.510

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.226

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.562

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.480

BZA0.12 mg/mL BenzamidearomaticAmides

0.163

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.044

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.638

H2O24 mM hydrogen peroxideDNAdamaging

-0.380

Levo10 ug/mL LevofloxacinDNAdamaging

-0.788

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.467

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.314

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.685

UVUV-irradiationDNAdamaging

-0.715

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.117

Antimycin12.5-50 ug/mL Antimycin A?

-0.339

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.079

PA_110-50 ug/mL Antitubercular compound PA-1?

0.006

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.756

PA8240.2-2 ug/mL PA-824?

0.385

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.013

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.287

Verapamil50 uM Verapamil?

-0.531

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.140

methoxatin10-20 ug/mL Methoxatin?